131 related articles for article (PubMed ID: 19964736)
21. Terbinafine, a unique oral antifungal: current perceptions.
Jain S; Sehgal VN
Int J Dermatol; 2000 Jun; 39(6):412-23. PubMed ID: 10944085
[No Abstract] [Full Text] [Related]
22. Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent.
Goodfield MJ; Rowell NR; Forster RA; Evans EG; Raven A
Br J Dermatol; 1989 Dec; 121(6):753-7. PubMed ID: 2532927
[TBL] [Abstract][Full Text] [Related]
23. Single dose treatment of fungal nail disease.
Shuster S; Munro CS
Lancet; 1992 Apr; 339(8800):1066. PubMed ID: 1349100
[No Abstract] [Full Text] [Related]
24. Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach.
Alpsoy E; Yilmaz E; Basaran E
J Dermatol; 1996 Apr; 23(4):259-62. PubMed ID: 8935341
[TBL] [Abstract][Full Text] [Related]
25. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Gupta AK; Gover MD; Lynde CW
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
[TBL] [Abstract][Full Text] [Related]
26. Iontophoresis across the proximal nail fold to target drugs to the nail matrix.
Manda P; Sammeta SM; Repka MA; Murthy SN
J Pharm Sci; 2012 Jul; 101(7):2392-7. PubMed ID: 22487899
[TBL] [Abstract][Full Text] [Related]
27. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
Weaver TD; Jespersen DL
Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
[TBL] [Abstract][Full Text] [Related]
28. An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.).
Shemer A; Gupta AK; Amichai B; Farhi R; Baran R; Daniel CR; Daigle D; Foley KA
J Dermatolog Treat; 2016 Oct; 27(5):480-3. PubMed ID: 27032812
[TBL] [Abstract][Full Text] [Related]
29. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
Sigurgeirsson B; Elewski BE; Rich PA; Opper C; Cai B; Nyirady J; Bakshi R
J Dermatolog Treat; 2006; 17(1):38-44. PubMed ID: 16467022
[TBL] [Abstract][Full Text] [Related]
30. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
31. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement.
Baran R; Sigurgeirsson B; de Berker D; Kaufmann R; Lecha M; Faergemann J; Kerrouche N; Sidou F
Br J Dermatol; 2007 Jul; 157(1):149-57. PubMed ID: 17553051
[TBL] [Abstract][Full Text] [Related]
32. Determination of terbinafine in nail samples during systemic treatment for onychomycoses.
Dykes PJ; Thomas R; Finlay AY
Br J Dermatol; 1990 Oct; 123(4):481-6. PubMed ID: 2151303
[TBL] [Abstract][Full Text] [Related]
33. Treatment of superficial white onychomycosis with topical terbinafine cream.
Goodfield MJ; Evans EG
Br J Dermatol; 1999 Sep; 141(3):604-5. PubMed ID: 10583101
[No Abstract] [Full Text] [Related]
34. Pharmacokinetics of terbinafine in the nail.
Finlay AY
Br J Dermatol; 1992 Feb; 126 Suppl 39():28-32. PubMed ID: 1531925
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
Yadav P; Singal A; Pandhi D; Das S
Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
[TBL] [Abstract][Full Text] [Related]
36. Alteration of the diffusional barrier property of the nail leads to greater terbinafine drug loading and permeation.
Nair AB; Sammeta SM; Kim HD; Chakraborty B; Friden PM; Murthy SN
Int J Pharm; 2009 Jun; 375(1-2):22-7. PubMed ID: 19481686
[TBL] [Abstract][Full Text] [Related]
37. Onychomycosis--treatment, relapse and re-infection.
Hull PR
Dermatology; 1997; 194 Suppl 1():7-9. PubMed ID: 9154393
[TBL] [Abstract][Full Text] [Related]
38. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
[TBL] [Abstract][Full Text] [Related]
39. Intermittent terbinafine for toenail onychomycosis: is it effective? Results of a randomized pilot trial.
Warshaw EM; Carver SM; Zielke GR; Ahmed DD
Arch Dermatol; 2001 Sep; 137(9):1253. PubMed ID: 11559235
[No Abstract] [Full Text] [Related]
40. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
Epstein E
Arch Dermatol; 1998 Dec; 134(12):1551-4. PubMed ID: 9875192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
